Intermittent Androgen Deprivation Therapy-An Important Treatment Option for Prostate Cancer

被引：12

作者：

Klotz, Laurence ^{[1
]}

Higano, Celestia S. ^{[2
,3
]}

机构：

[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Urol, Toronto, ON, Canada

[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Med, Div Med Oncol,Dept Med, Seattle, WA 98195 USA

[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Med, Dept Urol, Seattle, WA 98195 USA

来源：

JAMA ONCOLOGY | 2016年 / 2卷 / 12期

关键词：

SUPPRESSION;

D O I：

10.1001/jamaoncol.2016.3138

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1531 / 1532

页数：2

共 12 条

[1] Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist [J].

Albertsen, Peter C. ;

Klotz, Laurence ;

Tombal, Bertrand ;

Grady, James ;

Olesen, Tine K. ;

Nilsson, Jan .

EUROPEAN UROLOGY, 2014, 65 (03) :565-573

[2]

BRUCHOVSKY N, 1990, CANCER RES, V50, P2275

[3] The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer [J].

Crook, Juanita .

CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) :258-264

[4] Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy [J].

Crook, Juanita M. ;

O'Callaghan, Christopher J. ;

Duncan, Graeme ;

Dearnaley, David P. ;

Higano, Celestia S. ;

Horwitz, Eric M. ;

Frymire, Eliot ;

Malone, Shawn ;

Chin, Joseph ;

Nabid, Abdenour ;

Warde, Padraig ;

Corbett, Thomas ;

Angyalfi, Steve ;

Goldenberg, S. Larry ;

Gospodarowicz, Mary K. ;

Saad, Fred ;

Logue, John P. ;

Hall, Emma ;

Schellhammer, Paul F. ;

Ding, Keyue ;

Klotz, Laurence .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (10) :895-903

[5] Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer [J].

Hershman, Dawn L. ;

Unger, Joseph M. ;

Wright, Jason D. ;

Ramsey, Scott ;

Till, Cathee ;

Tangen, Catherine M. ;

Barlow, William E. ;

Blanke, Charles ;

Thompson, Ian M. ;

Hussain, Maha .

JAMA ONCOLOGY, 2016, 2 (04) :453-461

[6] Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162) [J].

Hussain, Maha ;

Tangen, Catherine M. ;

Higano, Celestia ;

Schelhammer, Paul F. ;

Faulkner, James ;

Crawford, E. David ;

Wilding, George ;

Akdas, Atif ;

Small, Eric J. ;

Donnelly, Bryan ;

MacVicar, Gary ;

Raghavan, Derek .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3984-3990

[7] Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details [J].

Hussain, Maha ;

Tangen, Catherine ;

Higano, Celestia ;

Vogelzang, Nicholas ;

Thompson, Ian .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03) :280-U147

[8] Intermittent versus Continuous Androgen Deprivation in Prostate Cancer [J].

Hussain, Maha ;

Tangen, Catherine M. ;

Berry, Donna L. ;

Higano, Celestia S. ;

Crawford, E. David ;

Liu, Glenn ;

Wilding, George ;

Prescott, Stephen ;

Sundaram, Subramanian Kanaga ;

Small, Eric Jay ;

Dawson, Nancy Ann ;

Donnelly, Bryan J. ;

Venner, Peter M. ;

Vaishampayan, Ulka N. ;

Schellhammer, Paul F. ;

Quinn, David I. ;

Raghavan, Derek ;

Ely, Benjamin ;

Moinpour, Carol M. ;

Vogelzang, Nicholas J. ;

Thompson, Ian M., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (14) :1314-1325

[9]

KLOTZ LH, 1986, CANCER-AM CANCER SOC, V58, P2546, DOI 10.1002/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0.CO

[10]

2-N

← 1 2 →